Neurocrine Biosciences, Inc. (NBIX)
129.64
-3.80
(-2.85%)
USD |
NASDAQ |
Mar 05, 16:00
129.68
+0.04
(+0.03%)
After-Hours: 20:00
Neurocrine Biosciences Price : 129.64 for March 5, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Glaukos Corp. | 112.10 |
| Edgewise Therapeutics, Inc. | 28.39 |
| Nuvalent, Inc. | 100.13 |
| Marker Therapeutics, Inc. | 1.39 |
| CapsoVision, Inc. | 5.06 |
Price Related Metrics
| PE Ratio | 27.77 |
| PS Ratio | 4.642 |
| PEG Ratio | 0.6639 |
| Price to Book Value | 4.000 |
| Price to Free Cash Flow | 17.74 |
| Earnings Yield | 3.60% |
| Market Cap | 13.01B |
| PEGY Ratio | 0.6639 |
| Operating PE Ratio | 20.86 |
| Normalized PE Ratio | 26.93 |